Inhibition of concanavalin A-induced acute T cell dependent hepatic damage in mice by hypothyroidism

Liver

Volumn 19, Issue 3, 1999, Pages 206-211

  Shirin, Haim ^a,e   Dotan, Iris ^a   Papa, Moshe ^a   Maaravi, Yoram ^b   Aeed, Husein ^a   Zaidel, Lillian ^a   Matas, Zipora ^a   Bruck, Rafael ^a   Moss, Steven F ^d   Halpern, Zamir ^a   Oren, Ran ^c  

^a WOLFSON MEDICAL CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Acute hepatitis; Concanavalin A; Hypothyroidism

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CONCANAVALIN A; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; LACTATE DEHYDROGENASE; THYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEPATITIS; AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPOTHYROIDISM; INTRAVENOUS DRUG ADMINISTRATION; LIVER INJURY; MACROPHAGE; MALE; MOUSE; NONHUMAN; T LYMPHOCYTE; THYROID FUNCTION;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CONCANAVALIN A; CYTOKINES; HYPOTHYROIDISM; IMMUNITY, CELLULAR; INFLAMMATION; L-LACTATE DEHYDROGENASE; LIVER; MALE; METHIMAZOLE; MICE; MICE, INBRED BALB C; PROPYLTHIOURACIL; T-LYMPHOCYTES; THYROIDECTOMY; TIME FACTORS;

EID: 0032978510     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.1999.tb00037.x     Document Type: Article

References (47)

1. VOLPE R. Evidence that the immunosuppressive effects of antithyroid drugs are mediated through actins on the thyroid cell, modulating thyrocyte-immunocyte signaling: a review. Thyroid 1994; 4: 217-23.
2. LIU W K, TSUI K W, WONG C C. Repressed activity of peritoneal macrophages in methimazole induced hypothyroid mice. Virchows Arch 1993; 63: 131-6.
3. LIU W K. Expression of tumor necrosis factor and c fos genes in peritoneal macrophages of hypothyroid mice. Inflammation 1993; 17: 217-25.
4. LIU W K, NG T B. Effect of methimazole induced hypothyroidism on alveolar macrophages. Virchows Arch 1991; 60: 21-6.
5. TIEGS G, HENTSCHEL J, WENDEL A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992; 90: 196-203.
6. GANTNER F, LEIST M. LOSHE A W, et al. Concanavalin A induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995; 21: 190-8.
7. Lis H, SHARON N. Biological properties of lectins. In: LIENER I E, SHARON N, GOLDSTEIN I J. eds. The lectins: properties, function, and applications in biology and medicine. New-York: Academic, 1986: 265-91.
8. TRAUTWEIN C, RAKEMANN T, BRENNER D A, et al. Concanavalin A-induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in mice. Gastroenterology 1998; 114: 1035-45.
9. SEINO K I, KAYAGAKI N, TAKEDA K. et al. Contribution of Fas Ligand to T cell-mediated hepatic injury in mice. Gastroenterology 1997; 113: 1315-22.
10. WATANABE Y, MORITA M. AKAIKE T. Concanavalin A induced perforin-mediated but not Fas-mediated hepatic injury. Hepatology 1996; 24: 702-10.
11. GANTNER F, LEIST M, JILG S, et al. Tumor necrosis factor-induced hepatic DNA fragmentation as an early marker of T cell-dependent liver injury in mice. Gastroenterology 1995; 109: 166-76.
12. BRUCK R, SHIRIN H, HERSHKOVITZ R, et al. Analysis of Arg-Gly-Asp mimetics and soluble receptor of tumour necrosis factor as therapeutic modalities for concanavalin A induced hepatitis in mice. Gut 1997; 40: 133-8.
13. SIKULER E. Beta adrenergic blockers for portal hypertension: lessons from animal models. J Hepatol 1991; 12: 133-5.
14. BRAILLON A, LEE S S, VALLA D, et al. Comparative haemodynamic effects of betaxolol and propranolol in patients with cirrhosis. Scand J Gastroenterol 1988; 23: 691-5.
15. WARTOFSKY L. Diseases of the thyroid. In: Antony S Fauci ed. Harrison's principles of internal medicine. 14th ed. New York: McGraw-Hill, 1998: 2026.
16. ORREGO H, BLAKE J E, BLENDIS L M, et al. Long-term treatment of alcoholic liver disease with propylthiouracil. N Engl J Med 1987; 317: 1421-7.
17. ORREGO H, BLAKE J E, BLENDIS L M, et al. Long-term treatment of alcoholic liver disease with propylthiouracil. Part 2: Influence of drop-out rates and of continued alcohol consumption in a clinical trial. J Hepatol 1994; 20: 343-9.
18. OREN R, DOTAN I, PAPA M, et al. Inhibition of experimentally-induced liver cirrhosis in rats by hypothyroidism. Hepatology 1996; 24: 419-23.
19. OREN R, HILZENRAT N, MAARAVI Y, et al. Hemodynamic effects of hypothyroidism induced by methimazole in normal and portal hypertensive rats. Dig Dis Sci 1995; 40: 1941-5.
20. BRUCK R, OREN R, SHIRIN H, et al. Hypothyroidism minimizes liver damage and improves survival in rats with thioacetamide induced fulminant hepatic failure. Hepatology 1998; 27: 1013-20.
21. ELLIS G, GOLDBERG D M, SPOONER R J, et al. Serum enzyme tests in diseases of the liver and biliary tree. Am J Clin Pathol 1978; 70: 248-58.
22. TOTTERMAN T H, KARLSSON F A, BENGTSSON M, et al. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease. N Engl J Med 1987; 316: 15-22.
23. SINGER D S, KOHN L D, ZINGER H, et al. Methimazole prevents induction of experimental systemic lupus erythematosus in mice. J Immunol 1994; 153: 873-80.
24. FUJII T, SATO K, OZAWA M, et al. Effect of interleukin 1 (IL-1) on thyroid hormone metabolism in mice: stimulation by IL-1 of iodothyronine 5′ deiodinating activity (type I) in the liver. Endocrinology 1989; 124: 167-74.
25. OZAWA M, SATO K, HAN D C, et al. Effect of tumor necrosis factor alpha/cachectin on thyroid hormone metabolism in mice. Endocrinology 1988; 123: 1461-7.
26. PANG X P, HERSHMAN J M, SMITH V, et al. The mechanism of action of tumour necrosis factor-alpha and interleukin 1 on FRTL-5 rat thyroid cells. Acta Endocrinol 1990; 123: 203-10.
27. DOCTER R, KRENNING E P, DE JONG M, HENNEMANN G. The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin-Endocrinol (Oxf) 1993; 39: 499-518.
28. VAN DER POLL T, ROMIJN J A, WIERSINGA W M, et al. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab 1990; 71: 1567-72.
29. BARTALENA L, GRASSO L, BROGIONI S, et al. Interleukin 6 effects on the pituitary thyroid axis in the rat. Eur J Endocrinol 1994; 131: 302-6.
30. HERMUS R M, SWEEP C G, VAN DER MEER M J, et al. Continuous infusion of interleukin 1 beta induces a nonthyroidal illness syndrome in the rat. Endocrinology 1992; 131: 2139-46.
31. CHOPRA I J, SAKANE S, TECO G N. A study of the serum concentration of tumor necrosis factor alpha in thyroidal and nonthyroidal illnesses. J Clin Endocrinol Metals 1991; 72: 1113-6.
32. SHIRIN H, BRUCK R, AEED H, et al. Pentoxifylline prevents concanavalin A-induced hepatitis by reducing tumor necrosis factor a levels and inhibiting adhesion of T lymphocytes to extracellular matrix. J Hepatol 1998; 29: 60-7.
33. SHIRIN H, BRUCK R, AEED H, et al. Effects of intravenous immunoglobulins on T cell mediated, concanavalin A-induced hepatitis in mice. Liver 1997; 17: 275-80.
34. ESPEVIK T, NISSEN-MEYER J. A highly sensitive cell line, WEHI 164 clones 13, for measuring cytotoxic factor tumor necrosis factor from human monocytes. J Immunol Methods 1986; 95: 99-105.
35. OHASHI H, ITOH M. Effects of thyroid hormones on the lymphocyte phenotypes in rats: changes in lymphocyte subsets related to thyroid function. Endocr-Regul 1994; 28: 117-23.
36. KAI O, NAGASA H, SUZUKI M, et al. Effects of hypothyroidism with treatment of an anti-thyroid drug, propylthiouracil on immune responses in chickens. Vet Immunol Immunopathol 1993; 36: 123-35.
37. VOLPE R. Immunoregulation in autoimmune thyroid disease. Thyroid 1994; 4: 373-7.
38. CARMICHAEL F J, ORREGO H, SALDIVIA V, et al. Effect of propylthiouracil on the ethanol-induced increase in liver oxygen consumption in awake rats. Hepatology 1993; 18: 415-21.
39. KAWASAKI T, CARMICHAEL F J, GILES G, et al. Effects of propylthiouracil and methimazole on splanchnic hemodynamics in awake and unrestrained rats. Hepatology 1989; 10: 273-8.
40. SCHWEDES U, WDOWINSKI J M, SIEDE W H, et al. Effect of hypometabolism on cell injury. Klin Wochenschr 1986; 64: 146-8.
41. COOPER D S. Antithyroid drugs. N Engl J Med 1984; 311: 1353-9.
42. MULLER M J, BOKER K H W, SELBERG O. Are patients with liver cirrhosis hypermetabolic. Clinical Nutrition 1994; 13: 131-44.
43. GEERTS A, LAZOU J M, DE BLESER P, et al. Tissue distribution, quantitation and proliferation kinetics of fat-storing cells in carbon tetrachloride injured rat liver. Hepatology 1991; 13: 1193-202.
44. McLVER M A. Increased susceptibility to chloroform poisoning produced in the albino rat by injection of crystalline thyroxin. Proc Soc Exp Biol Med 1940; 45: 201.
45. McLVER M A, WINTER E A. Further studies on increased susceptibility to chloroform poisoning produced in the albino rat by injection of crystalline thyroxin. J Clin Invest 1942; 21: 191.
46. MANNS M P, KRUGER M. Immunogenetics of chronic liver diseases. Gastroenterology 1994; 106: 1676-97.
47. THOMPSON N P, LEADER S, JAMIESON C R et al. Reversible jaundice in primary biliary cirrhosis due to hyperthyroidism. Gastroenterology 1994; 106: 1342-3.